BTA-9881

BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.

1646857-24-0

≥ 2 years

>98% (HPLC)

390.82

C21H15ClN4O2

Research use only, not for human use.

RSV

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP3-06352IR 0.1 mL

Ask

FAB52401Y 0.1 mL

Ask

abx238599 100 µg

Ask

40908091 4x 500 ng

Ask

MBS8231981-01 15 nmol

Ask

MBS8231981-02 30 nmol

Ask